Turk Ilac Ve Serum Sanayi Anonim Sirketi Valuation
Is TRILC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of TRILC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: TRILC (TRY12.4) wird über unserer Schätzung des Fair Value (TRY7.38) gehandelt.
Deutlich unter dem Marktwert: TRILC über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TRILC?
Other financial metrics that can be useful for relative valuation.
| What is TRILC's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | ₺2.89b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.7x |
| Enterprise Value/EBITDA | 22.1x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does TRILC's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.4x | ||
DEVA Deva Holding | 6.3x | n/a | ₺13.7b |
GENIL Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi | 19x | n/a | ₺19.5b |
AGP AGP | 13.8x | n/a | PK₨21.7b |
VIT Vitura Health | 10.4x | n/a | AU$97.9m |
TRILC Turk Ilac Ve Serum Sanayi Anonim Sirketi | 30.6x | n/a | ₺2.9b |
Price-To-Earnings gegen Gleichaltrige: TRILC ist auf der Grundlage des Price-To-Earnings Verhältnisses (23.4x) im Vergleich zum Durchschnitt der Vergleichsgruppe (-31.2x) teuer.
Price to Earnings Ratio vs Industry
How does TRILC's PE Ratio compare vs other companies in the Asian Pharmaceuticals Industry?
Price-To-Earnings gegen Industrie: TRILC ist teuer, wenn man sein Price-To-Earnings Verhältnis (24.7x) mit dem Asian Pharmaceuticals Branchendurchschnitt (24.5x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is TRILC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 30.6x |
| Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von TRILC für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.